All Posts
Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomized controlled trials and cohort studies.
6 May, 2022 | 10:59h | UTCRelated:
Commentary on Twitter
Read a new #systematicreview and meta-analysis of RCTs and cohort studies on the safety of #Ezetimibe in lipid-lowering treatment. ▶️ https://t.co/mr4H5MfVdP#VisualAbstract #RapidRecommendations@bmj_latest @theMAGICapp pic.twitter.com/OLg0HZr8D3
— BMJMedicine (@BMJMedicine) May 5, 2022
Long COVID: aiming for a consensus.
6 May, 2022 | 11:03h | UTCLong COVID: aiming for a consensus – The Lancet Respiratory Medicine
Commentary on Twitter
There is an urgent need for unification of terminology for the sequelae of #SARSCoV2 infection to ensure that research is directed towards and translated into interventional trials to improve outcomes
NEW Comment—#LongCOVID: aiming for a consensushttps://t.co/dZO4rBVCSY pic.twitter.com/H5ezqL0RLb
— The Lancet Respiratory Medicine (@LancetRespirMed) May 5, 2022
Position statement on acute oxygen use in adults: ‘swimming between the flags’.
6 May, 2022 | 10:56h | UTCRelated:
Guideline Summary: New guidance on the perioperative management of diabetes.
6 May, 2022 | 10:55h | UTCNew guidance on the perioperative management of diabetes – Clinical Medicine Journal
Original Guideline: Perioperative Care of People with Diabetes Undergoing Surgery
Related:
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines.
6 May, 2022 | 10:53h | UTC
A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles.
6 May, 2022 | 10:52h | UTC
Left ventricular remodeling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
6 May, 2022 | 10:50h | UTC
Systematic Review: Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
6 May, 2022 | 10:47h | UTCSummary: Cannabis and cannabinoids for people with multiple sclerosis – Cochrane Library
Commentary on Twitter
💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms.
🤔 Does it work? Are there harms?
📚 Cochrane systematic review looks at 25 RCTs ➡️ https://t.co/HCt6Cx3suo#MedicalMarijuana #MultipleSclerosis pic.twitter.com/wjDTXXEciM— The Cochrane Library (@CochraneLibrary) May 5, 2022
M-A: Wearable cuffless blood pressure monitoring devices.
6 May, 2022 | 10:48h | UTC
Commentary on Twitter
Wearable cuffless blood pressure monitoring devices: a systematic review and meta-analysis https://t.co/UP2M81OuzB #EHJDigital @BruiningNico @rafavidalperez @pauldub67 @clara_chow pic.twitter.com/8ouQvSH8mQ
— European Society of Cardiology Journals (@ESC_Journals) May 4, 2022
Systematic Review: Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression.
6 May, 2022 | 10:37h | UTCRelated:
Discontinuing antidepressants: Pearls and pitfalls.
A method for tapering antipsychotic treatment that may minimize the risk of relapse
Systematic Review: Managing Antidepressant Discontinuation
Randomized controlled trial: preventive cognitive therapy for prevention of depressive recurrence
Global inequalities in the double burden of malnutrition and associations with globalization: a multilevel analysis of Demographic and Healthy Surveys from 55 low-income and middle-income countries, 1992–2018.
6 May, 2022 | 10:38h | UTC
Commentary from the author on Twitter (thread – click for more)
https://twitter.com/e_seferidi/status/1491354228581105665
Giving people money with no strings attached is good for their health, dozens of studies indicate.
6 May, 2022 | 10:44h | UTC
Review: Pharmacologic management of persistent pain in cancer survivors.
6 May, 2022 | 10:34h | UTCPharmacologic Management of Persistent Pain in Cancer Survivors – Drugs
Review: Overcoming Stenotrophomonas maltophilia resistance for a more rational therapeutic approach.
6 May, 2022 | 10:31h | UTC
Review: Non-invasive testing and surrogate markers in invasive fungal diseases.
6 May, 2022 | 10:29h | UTC
Is Artificial Intelligence (AI) a pipe dream? Why legal issues present significant hurdles to ai autonomy.
6 May, 2022 | 10:32h | UTC
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment.
6 May, 2022 | 10:27h | UTC
M-A: Body position for preventing ventilator-associated pneumonia for critically ill patients.
6 May, 2022 | 10:23h | UTC
Mobile phone-based interventions for mental health: A systematic meta-review of 14 meta-analyses of randomized controlled trials.
6 May, 2022 | 10:25h | UTC
Review: Outcomes of Enhanced Recovery after Surgery (ERAS) in gynecologic oncology.
6 May, 2022 | 10:22h | UTC
Review: Advances in radiation oncology for the treatment of cervical cancer.
6 May, 2022 | 10:20h | UTCAdvances in Radiation Oncology for the Treatment of Cervical Cancer – Current Oncology
Perspective | Does glycemic index matter for weight loss and obesity prevention? Examination of the evidence on “fast” compared with “slow” carbs.
6 May, 2022 | 10:19h | UTC
Ten tips to optimize vasopressors use in the critically ill patient with hypotension.
5 May, 2022 | 11:07h | UTCTen tips to optimize vasopressors use in the critically ill patient with hypotension – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Vasopressors in #ICU
1️⃣set MAP/DBP goals
2️⃣individualize
3️⃣may⬇️+ve fluid balance
4️⃣reassess fluid status/CO
5️⃣change mechanism as 2 line
6️⃣high doses?? hydrocortisone
7️⃣vasopressin in RV failure
8️⃣no MAX dose
9️⃣EN can be initiated
🔟can be safe in PVC
🖇 https://t.co/v6Q9nfy5KY pic.twitter.com/8YEDaOQBOQ— Intensive Care Medicine (@yourICM) May 4, 2022
Variation in revascularization use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study.
5 May, 2022 | 11:04h | UTCNews Release: Study finds large differences in heart attack care across six high income countries – British Medical Journal
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
5 May, 2022 | 11:06h | UTCNews Release: Experts recommend additional cholesterol lowering drugs for adults at high heart disease risk – British Medical Journal


